Abstract:AIM: To investigate the influence of the expression of nm23 gene on the prognosis in patients with breast cancer. METHODS: Sixty female patients with breast cancer of 26-63 years old, who received radical treatment in the Department of General Surgery, the Second Affiliated Hospital of Harbin Medical University from June 1997 to December 1998, participated in the study, including 30 cases had transfer of axillary lymph node and 30 cases had no transfer of axillary lymph node. According to the clinical staging standard of International Anti-Cancer Association, the patients were classified into 30 cases of stage, 16 cases of stage Ⅱ, 14 cases of stage Ⅲ and none was stage Ⅳ, another 20 patients with breast cystic hyperplasia at the same period were randomly selected as controls. The expression of nm23 gene was detected with immunohistochemical S-P method in both groups, and the associations of the positive expression of nm23 gene with the clinical pathological indexes, distant transfer and survival rate were observed. The buffy cell plasm was taken as the positive expression of nm23 gene. RESULTS: All the 60 patients with breast cancer and 20 patients with breast cystic hyperplasia were involved in the analysis of results. ① The positive expression of nm23 gene in breast cancer and breast cystic hyperplasia: It was significantly higher in breast cancer than in breast cystic hyperplasia (60.0%, 30.0%, P < 0.05). ② Association between the positive expression of nm23 gene and clinical pathological indexes: The positive expression rate of nm23 gene was significantly higher in patients of clinical stages Ⅰ-Ⅱ than in those of stage Ⅲ (67.4%, 35.7%, P < 0.05), significantly higher in patients without transfer of axillary lymph node than in those with transfer of axillary lymph node (86.7%, 33.3%, P <0.05), significantly higher in patients with hormone receptor (+) than in those with hormone receptor (-) (72.7%, 25.0%, P < 0.05), also significantly higher in the patients with progestogen receptor (+) than in those with progestogen receptor (-) (75.0%, 30.0%, P < 0.05). ③ Correlation of the positive expression of nm23 gene with distant transfer and survival rate: The positive expression of nm23 gene was significantly higher in the patients without distant transfer those with distant transfer (73.4%, 14.3%, P < 0.05), and survival rate of 5 years was significantly higher in the patients with positive expression of nm23 gene than in those with negative ones (94.4%, 50.0%, P < 0.05). CONCLUSION: It is the most helpful in evaluating the prognosis of patients with breast cancer and directing clinical treatment to observe the expression of nm23 gene.

Prognostic Value and Clinicopathologic Significance of Nm23 in Various Cancers: A Systematic Review and Meta-Analysis

Prognostic and clinicopathological value of NM23 expression in patients with breast cancer: A systematic review and meta-analysis

Prognostic and Clinicopathological Significance of Nm23-H1 Expression in Non-Small Cell Lung Cancer: A Meta-Analysis

EVALUATION OF THE PROGNOSTIC VALUE OF Nm23 GENE EXPRESSION IN BREAST CANCER

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Relation of NM23-H1 and CD44v6 Expression to Patient's Prognosis in the Non-Small Cell Lung Cancer Without Lymph Node Metastasis

Relationship Between Mrna Expression of Metastasis Suppressor Gene Nm23 and Clinicopathological Features and Prognosis of Non Small Cell Lung Carcinoma

Expression and clinical value of nm23 gene in primary breast carcinoma

Effect of nm23 gene expression on the survival and other prognostic indexes of patients with breast cancer

Expression of Nm23-H1 Gene Product in Nasopharyngeal Carcinoma and Its Clinical Significance

Study on the Expression of Nm23 and Its Clinical Significance in Lung Neoplasms

Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues Are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma

Nm23-H1 Expression in Nasopharyngeal Carcinoma: Correlation with Clinical Outcome.

Relationship between product of nm23 gene and metastasis prognosis of lung cancer

Expression of Nm23-H_1 Protein in Human Colorectal Carcinoma

nm23-H1 Protein Expression and Gene Mutation in 150 Patients with Non-Hodgkin's Lymphomas

Survival Advantage and Clinicopathological Significance of Microrna-22 in Cancers: a Meta-Analysis.

Correlation Between Nm23-H1 Expression and Metastasis in Patients with Gastric Cancer

NORTHERN BLOT ANALYSIS OF Nm23 GENE EXPRESSION IN HUMAN LUNG CANCER

Clinical Value of Nm23-H1 and Survivin Protein Expression in Nasopharyngeal Carcinoma

Analysis of the Expression of nm23 Protein and the Dangerous Factors of Bone Metastasis in Breast Carcinoma